First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure

被引：39
|
作者：
Esmore, DS
Kaye, D
Salamonsen, R
Buckland, M
Rowland, M
Negri, J
Rowley, Y
Woodard, J
Begg, JR
Ayre, P
Rosenfeldt, FL
机构：
[1] Alfred Hosp, Dept Cardiothorac Surg, Prahran, Vic 3181, Australia
[2] Alfred Hosp, Dept Cardiol, Prahran, Vic 3181, Australia
[3] Alfred Hosp, Dept Anaesthesia & Intens Care, Prahran, Vic 3181, Australia
[4] Ventracor Ltd, Chatswood, NSW, Australia
[5] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2005年 / 24卷 / 08期
关键词：
D O I：
10.1016/j.healun.2005.01.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The VentrAssist device left ventricular assist system, designed for permanent implantation, is a novel centrifugal pump with a hydrodynamically suspended rotor. The first human implant was into a 72-year-old man with New York Heart Association (NYHA) class IV heart failure due to idiopathic dilated cardiomyopathy. The implant and recovery were uneventful, and the patient survives at 17 months, is NYHA class 11, and lives at home. This device shows promise in end-stage. heart failure for permanent implantation and bridge to transplantation.
引用
收藏
页码：1150 / 1154
页数：5
相关论文
共 50 条
  • [21] Clinical outcomes of patients with end-stage heart failure treated with left ventricular assist devices
    Di Carlo, Marta
    Marchetti, Maria Francesca
    Tramontin, Corrado
    Corda, Marco
    Porcu, Maurizio
    Agus, Elena
    Boi, Giacomo
    Cirio, Emiliano
    Meloni, Luigi
    Montisci, Roberta
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [22] Clinical outcomes of patients with end-stage heart failure treated with left ventricular assist devices
    Di Carlo, Marta
    Marchetti, Maria Francesca
    Tramontin, Corrado
    Corda, Marco
    Porcu, Maurizio
    Agus, Elena
    Boi, Giacomo
    Cirio, Emiliano
    Meloni, Luigi
    Montisci, Roberta
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [23] Clinical Experience With HeartWare Left Ventricular Assist Device in Patients With End-Stage Heart Failure
    Popov, Aron Frederik
    Hosseini, Morteza Tavakkoli
    Zych, Bartlomiej
    Mohite, Prashant
    Hards, Rachel
    Krueger, Heike
    Bahrami, Toufan
    Amrani, Mohamed
    Simon, Andre Ruediger
    ANNALS OF THORACIC SURGERY, 2012, 93 (03): : 810 - 815
  • [24] Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: A systematic review and economic evaluation
    Clegg, Andrew J.
    Scott, David A.
    Loveman, Emma
    Colquitt, Jill
    Royle, Pam
    Bryant, Jackie
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (02) : 261 - 268
  • [25] Permanent left ventricular assist device for end-stage heart failure: First successful implantation of the axial flow HeartMate II rotary pump as destination therapy for heart failure in Israel
    Amir, Offer
    Aravot, Dan
    Pizov, Reuven
    Orlov, Boris
    Eden, Arieh
    Shiran, Avinoam
    Karkabi, Basheer
    Sabbag, Latif
    Zlotnick, Amnon Y.
    Ammar, Ronny
    Halon, David A.
    Lewis, Basil S.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2007, 9 (12): : 887 - 888
  • [26] Heart Transplantation and Left Ventricular Assist Device Therapy: Two Comparable Options in End-Stage Heart Failure?
    Garbade, Jens
    Barten, Markus J.
    Bittner, Hartmuth B.
    Mohr, Friedrich-Wilhelm
    CLINICAL CARDIOLOGY, 2013, 36 (07) : 378 - 382
  • [27] Left ventricular assist device as destination therapy for end stage heart failure: the right time for the right patients
    Fukunaga, Naoto
    Rao, Vivek
    CURRENT OPINION IN CARDIOLOGY, 2018, 33 (02) : 196 - 201
  • [28] Mechanical ventricular assistance as destination therapy for end-stage heart failure: has it become a first line therapy?
    Bonacchi, Massimo
    Harmelin, Guy
    Bugetti, Marco
    Sani, Guido
    FRONTIERS IN SURGERY, 2015, 2
  • [29] TNFα in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device
    Bruggink, A. H.
    van Oosterhout, M. F. M.
    De Jonge, N.
    Gmelig-Meyling, F. H. J.
    De Weger, R. A.
    TRANSPLANT IMMUNOLOGY, 2008, 19 (01) : 64 - 68
  • [30] The role of left ventricular assist device therapy for patients with end-stage heart failure - serbian experience
    Nestorovic, E. Emilija
    Milic, N.
    Putnik, S.
    Terzic, D.
    Ristic, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 83 - 83
12345